Delivery Order SPE2DB22D3016-SPE2DB25FAZJ7

Award Date 6/13/25
Potential Completion Date 7/8/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,802.10 firm fixed-price delivery order contract is for the supply of DARZALEX FASPRO, a pharmaceutical product, with a performance period extending until July 8, 2025. The contract is not set aside and involves open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 firm fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,881.20 firm fixed-price delivery order is for DARZALEX FASPR 1800 1S, a medical product, with a completion date of February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $17,940.63, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract provides for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product,...
This federal contract award, valued at $110,408.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO, a specialty medication, and is a Firm Fixed Price Delivery Order that runs through November 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $110,408.40 firm fixed-price delivery order is for the supply of DARZALEX FASPRO, a specialty medication, with a completion date of December 3, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,841.68 firm fixed price delivery order contract is for the supply of 1,800mg-30,000 15ml vials of the drug DARZALEX FASPRO, with a performance period ending on March 7, 2025. The contract was awarded on February 13, 2025 and was not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $57,112.20 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024. The contract is a firm fixed-price Delivery Order with a completion date of January 10, 2025. This award is likely part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $22,081.68 firm fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has a completion date of September 25, 2024. AmerisourceBergen holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAZJ7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,960.42 firm fixed-price delivery order is for the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a period of performance through July 8, 2025 and does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This award enables the company to supply a wide range of pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 9/12/25, 10:54 AM